95 search results for Caspase-3
| # | SuperPathway Name | Genes Count | Relevance Score | |||
|---|---|---|---|---|---|---|
| 1 | Programmed Cell Death | 213 | 0.446 | |||
|
||||||
| 2 | MTHFR deficiency | 21 | 0.446 | |||
|
||||||
| 3 | Apoptosis and Autophagy | 185 | 0.446 | |||
|
||||||
| 4 | DNA IR-double strand breaks and cellular response via ATM | 65 | 0.446 | |||
|
||||||
| 5 | Small cell lung cancer | 96 | 0.446 | |||
|
||||||
| 6 | p75 NTR receptor-mediated signalling | 182 | 0.446 | |||
|
||||||
| 7 | Gastrin signaling pathway | 112 | 0.446 | |||
|
||||||
| 8 | Alzheimer's disease and miRNA effects | 267 | 0.446 | |||
|
||||||
| 9 | Death Receptor Signaling Pathway | 119 | 0.446 | |||
|
||||||
| 10 | Complement cascade | 176 | 0.446 | |||
|
||||||
| 11 | Host-pathogen interaction of human coronaviruses - apoptosis | 21 | 0.446 | |||
|
||||||
| 12 | Akt Signaling | 682 | 0.446 | |||
|
||||||
| 13 | Acute viral myocarditis | 75 | 0.446 | |||
|
||||||
| 14 | VEGF Pathway (Tocris) | 58 | 0.446 | |||
|
||||||
| 15 | Amyotrophic lateral sclerosis (ALS) | 36 | 0.446 | |||
|
||||||
| 16 | a6b1 and a6b4 Integrin signaling | 37 | 0.446 | |||
|
||||||
| 17 | MAPK Signaling: Mitogens | 108 | 0.446 | |||
|
||||||
| 18 | Parkinson's disease pathway | 38 | 0.446 | |||
|
||||||
| 19 | PAK Pathway | 686 | 0.446 | |||
|
||||||
| 20 | MAPK signaling pathway | 244 | 0.446 | |||
|
||||||
| 21 | Syndecan-2-mediated signaling events | 34 | 0.446 | |||
|
||||||
| 22 | Nanog in Mammalian ESC Pluripotency | 534 | 0.446 | |||
|
||||||
| 23 | Apoptosis and survival FAS signaling cascades | 108 | 0.446 | |||
|
||||||
| 24 | Hepatocyte growth factor receptor signaling | 115 | 0.446 | |||
|
||||||
| 25 | Apoptotic cleavage of cellular proteins | 52 | 0.446 | |||
|
||||||
| 26 | NGF Pathway | 87 | 0.446 | |||
|
||||||
| 27 | MIF Mediated Glucocorticoid Regulation | 681 | 0.446 | |||
|
||||||
| 28 | Endometrial cancer | 201 | 0.446 | |||
|
||||||
| 29 | Presenilin-Mediated Signaling | 142 | 0.446 | |||
|
||||||
| 30 | fMLP Pathway | 266 | 0.446 | |||
|
||||||
| 31 | IL-18 signaling pathway | 50 | 0.446 | |||
|
||||||
| 32 | miRNA regulation of p53 pathway in prostate cancer | 32 | 0.446 | |||
|
||||||
| 33 | Network map of SARS-CoV-2 signaling pathway | 48 | 0.446 | |||
|
||||||
| 34 | ERK Signaling | 1185 | 0.446 | |||
|
||||||
| 35 | TNF Superfamily - Human Ligand-Receptor Interactions and their Associated Functions | 170 | 0.446 | |||
|
||||||
| 36 | Celecoxib Pathway, Pharmacodynamics | 58 | 0.446 | |||
|
||||||
| 37 | Development EGFR signaling pathway | 154 | 0.446 | |||
|
||||||
| 38 | Oxidative damage response | 40 | 0.446 | |||
|
||||||
| 39 | CASP8 activity is inhibited | 57 | 0.446 | |||
|
||||||
| 40 | Role of Calcineurin-dependent NFAT signaling in lymphocytes | 36 | 0.446 | |||
|
||||||
| 41 | Pathogenesis of ALS | 25 | 0.446 | |||
|
||||||
| 42 | LPA receptor mediated events | 47 | 0.446 | |||
|
||||||
| 43 | Prolactin Signaling | 432 | 0.446 | |||
|
||||||
| 44 | Overview of interferons-mediated signaling pathway | 168 | 0.446 | |||
|
||||||
| 45 | p53 Signaling | 117 | 0.446 | |||
|
||||||
| 46 | SMAC (DIABLO) binds to IAPs | 13 | 0.446 | |||
|
||||||
| 47 | CKAP4 signaling pathway map | 108 | 0.446 | |||
|
||||||
| 48 | LT-BetaR Pathway | 56 | 0.446 | |||
|
||||||
| 49 | Other interleukin signaling | 24 | 0.446 | |||
|
||||||
| 50 | TNFR1 Pathway | 190 | 0.446 | |||
|
||||||
| 51 | Posttranslational regulation of adherens junction stability and dissassembly | 48 | 0.446 | |||
|
||||||
| 52 | IL-17 Family Signaling Pathways | 108 | 0.446 | |||
|
||||||
| 53 | Calcineurin-regulated NFAT-dependent transcription in lymphocytes | 51 | 0.446 | |||
|
||||||
| 54 | G-protein signaling_Regulation of RAC1 activity | 48 | 0.446 | |||
|
||||||
| 55 | Integrin Pathway | 570 | 0.446 | |||
|
||||||
| 56 | Prion disease pathway | 32 | 0.446 | |||
|
||||||
| 57 | 14-3-3 and Regulation of BAD Activity | 32 | 0.446 | |||
|
||||||
| 58 | Cytokine Signaling in Immune system | 732 | 0.446 | |||
|
||||||
| 59 | DREAM Repression and Dynorphin Expression | 250 | 0.446 | |||
|
||||||
| 60 | Ceramide Pathway | 93 | 0.446 | |||
|
||||||
| 61 | Apoptotic Pathways in Synovial Fibroblasts | 731 | 0.446 | |||
|
||||||
| 62 | ERK pathway in Huntington's disease | 15 | 0.446 | |||
|
||||||
| 63 | Integrated breast cancer pathway | 150 | 0.446 | |||
|
||||||
| 64 | Granzyme Pathway | 37 | 0.446 | |||
|
||||||
| 65 | p75(NTR)-mediated signaling | 61 | 0.446 | |||
|
||||||
| 66 | NF-kappaB Pathway | 152 | 0.446 | |||
|
||||||
| 67 | Copper homeostasis | 51 | 0.446 | |||
|
||||||
| 68 | miRNA regulation of DNA damage response | 74 | 0.446 | |||
|
||||||
| 69 | Gemtuzumab ozogamicin Pathway, Pharmacokinetics/Pharmacodynamics | 23 | 0.446 | |||
|
||||||
| 70 | Signaling by Hippo | 20 | 0.446 | |||
|
||||||
| 71 | DYRK1A involvement regarding cell proliferation in brain development | 62 | 0.446 | |||
|
||||||
| 72 | Nur77 Signaling in T-Cell | 35 | 0.446 | |||
|
||||||
| 73 | Spinal cord injury | 115 | 0.446 | |||
|
||||||
| 74 | Sudden infant death syndrome (SIDS) susceptibility pathways | 159 | 0.446 | |||
|
||||||
| 75 | CTL Mediated Apoptosis | 38 | 0.446 | |||
|
||||||
| 76 | Netrin-UNC5B signaling pathway | 52 | 0.446 | |||
|
||||||
| 77 | Burn wound healing | 75 | 0.446 | |||
|
||||||
| 78 | IL-26 signaling pathways | 35 | 0.446 | |||
|
||||||
| 79 | Signal Transduction | 2590 | 0.446 | |||
|
||||||
| 80 | G-protein signaling_Regulation of CDC42 activity | 32 | 0.446 | |||
|
||||||
| 81 | Orexin receptor pathway | 24 | 0.446 | |||
|
||||||
| 82 | RIPK1-mediated regulated necrosis | 60 | 0.446 | |||
|
||||||
| 83 | Toll-like receptor signaling pathway | 285 | 0.446 | |||
|
||||||
| 84 | Allograft rejection | 93 | 0.446 | |||
|
||||||
| 85 | 4-1BB Pathway | 173 | 0.446 | |||
|
||||||
| 86 | RhoGDI Pathway | 181 | 0.446 | |||
|
||||||
| 87 | Innate Immune System | 2025 | 0.446 | |||
|
||||||
| 88 | Extracellular matrix organization | 300 | 0.446 | |||
|
||||||
| 89 | Androgen receptor network in prostate cancer | 105 | 0.446 | |||
|
||||||
| 90 | Intrinsic Pathway for Apoptosis | 55 | 0.446 | |||
|
||||||
| 91 | Colorectal Cancer Metastasis | 165 | 0.446 | |||
|
||||||
| 92 | Hepatitis C and hepatocellular carcinoma | 55 | 0.446 | |||
|
||||||
| 93 | Corticotropin-releasing hormone signaling pathway | 91 | 0.446 | |||
|
||||||
| 94 | Regucalcin in proximal tubule epithelial kidney cells | 22 | 0.446 | |||
|
||||||
| 95 | S-1P Stimulated Signaling | 96 | 0.446 | |||
|
||||||